video thumbnail

Epstein Barr Virus Reactivation in COVID

Duration: 23:28

Write A New Comment

0 Comments

Epstein Barr Virus Reactivation in COVID

A study from China published in May 2021 concluded: We find a high incidence of EBV coinfection in COVID-19 patients. EBV/SARS-CoV-2 coinfection was associated with fever and increased inflammation. EBV reactivation may be associated with the severity of COVID-19. The reactivation of EBV may also be the cause of the COVID long haul symptoms. Let's review.

About infectious Mononucleosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670567/

Study published in nature on May 21st 2021
https://www.nature.com/articles/s41598-021-90351-y

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

COVID-19

Related Videos